View in EDS

Phase II study of the PI3K inhibitor BKM120 in patients with advanced or recurrent endometrial carcinoma: a stratified type I-type II study from the GINECO group.

Saved in:

Bibliographic Details
Title:	Phase II study of the PI3K inhibitor BKM120 in patients with advanced or recurrent endometrial carcinoma: a stratified type I-type II study from the GINECO group.
Authors:	Heudel, P-E¹, Fabbro, M², Roemer-Becuwe, C³, Kaminsky, M C⁴, Arnaud, A⁵, Joly, F⁶, Roche-Forestier, S⁷, Meunier, J⁸, Foa, C⁹, You, B¹⁰, Priou, F¹¹, Tazi, Y¹², Floquet, A¹³, Selle, F¹⁴, Berton-Rigaud, D¹⁵, Lesoin, A¹⁶, Kalbacher, E¹⁷, Lortholary, A¹⁸, Favier, L¹⁹, Treilleux, I¹
Source:	British Journal of Cancer. 1/31/2017, Vol. 116 Issue 3, p303-309. 7p. 4 Charts, 1 Graph.
Database:	Academic Search Ultimate

Description
ISSN:	00070920
DOI:	10.1038/bjc.2016.430